Get the Stockscreener App
3.185
10.78%
-0.385
Anbio Biotechnology Stock (NNNN) Forecast
The Anbio Biotechnology (NNNN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.745, representing a +48.98% increase from the current price of $3.185. The highest analyst price target is $5.6342, and the lowest is $3.8557.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NNNN Price Target
Average 28.71
(+801.32% Upside)
Is Anbio Biotechnology (NNNN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 18.56 | Buy |
| STOCH(9,6) | 9.5658 | Buy |
| STOCHRSI(14) | 5.3333 | Buy |
| MACD(12,26) | -0.8497 | Sell |
| ADX(14) | 24.86 | Neutral |
| William %R | -97.29 | Buy |
| CCI(14) | -141.19 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.4885
Sell
|
4.4082
Sell
|
| MA20 |
5.2372
Sell
|
5.0669
Sell
|
| MA50 |
6.7054
Sell
|
7.0432
Sell
|
| MA100 |
11.23
Sell
|
10.93
Sell
|
| MA200 |
19.00
Sell
|
17.14
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NNNN could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on NNNN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 18.56 indicates that NNNN is oversold. This indicates that NNNN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 9.5658 indicates that NNNN is oversold. This indicates that NNNN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.3333 indicates that NNNN is oversold. This suggests that NNNN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.86 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -141.19 indicates that NNNN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NNNN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Anbio Biotechnology financial reports and earnings history, Anbio Biotechnology (NNNN) stock could reach $32.35 by 2030, $10.04 by 2040 and $26.85 by 2050. See the projected annual prices until 2050 of the Anbio Biotechnology stock below:
- Anbio Biotechnology (NNNN) is expected to reach an average price of $13.68 in 2035, with a high prediction of $41.91 and a low estimate of $12.66. This indicates an $329.57% rise from the last recorded price of $3.185.
- Anbio Biotechnology (NNNN) stock is projected to chart a bullish course in 2040, with an average price target of $9.9007, representing an $210.85% surge from its current level. The forecast ranges from a conservative $9.8391 to a sky-high $10.04.
- Our analysts predict Anbio Biotechnology (NNNN) to jump 248.60% by 2045, soaring from $7.0528 to an average price of $11.10, potentially reaching $17.02. While $7.0528 is the low estimate, the potential upside is significant.
- Anbio Biotechnology (NNNN) stock is expected to climb by 2050, reaching an average of $4.7396, a $48.81% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.85 and $1.7884, respectively, highlighting the market's uncertainty.
Anbio Biotechnology Stock (NNNN) Year by Year Forecast
Anbio Biotechnology Stock (NNNN) Price Forecast for 2026
The predicted value for Anbio Biotechnology (NNNN) in 2026 is set at an average of $23.92. Estimates vary from a peak of $44.44 to a trough of $3.40, indicating an +651.02% surge from the present price of $3.185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $5.3114 | $3.8557 | $5.6342 | +66.76% |
| December, 2026 | $4.4156 | $3.7585 | $5.6799 | +38.64% |
Anbio Biotechnology Stock (NNNN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Anbio Biotechnology (NNNN) is $28.80, with a high forecast of $53.66 and a low forecast of $3.9527. This indicates an +804.37% increase from the last price of $3.185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.4598 | $3.9527 | $5.5998 | +71.42% |
| February, 2027 | $6.6141 | $4.9584 | $6.9897 | +107.66% |
| March, 2027 | $47.26 | $6.5626 | $51.60 | +1,384% |
| April, 2027 | $40.83 | $36.23 | $53.66 | +1,182% |
| May, 2027 | $45.92 | $38.75 | $53.01 | +1,342% |
| June, 2027 | $35.36 | $31.20 | $46.16 | +1,010% |
| July, 2027 | $21.11 | $20.20 | $49.45 | +562.87% |
| August, 2027 | $21.62 | $8.6595 | $31.12 | +578.66% |
| September, 2027 | $31.72 | $19.32 | $42.92 | +895.90% |
| October, 2027 | $30.78 | $25.56 | $41.25 | +866.52% |
| November, 2027 | $23.00 | $16.77 | $42.71 | +622.02% |
| December, 2027 | $21.87 | $18.42 | $28.80 | +586.68% |
Anbio Biotechnology Stock (NNNN) Price Forecast for 2028
In 2028, Anbio Biotechnology (NNNN) is projected to reach an average price of $17.87, with a high projection of $34.54 and a low estimate of $1.20. This indicates an +461.12% rise from the last price of $3.185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.52 | $20.45 | $28.32 | +701.37% |
| February, 2028 | $24.25 | $23.84 | $31.35 | +661.31% |
| March, 2028 | $21.43 | $20.44 | $34.54 | +572.90% |
| April, 2028 | $12.19 | $11.07 | $21.46 | +282.61% |
| May, 2028 | $8.419 | $6.7933 | $12.18 | +164.33% |
| June, 2028 | $6.2232 | $5.1547 | $12.34 | +95.39% |
| July, 2028 | $4.896 | $3.7175 | $6.3218 | +53.72% |
| August, 2028 | $2.2003 | $2.1503 | $5.2046 | -30.92% |
| September, 2028 | $2.8014 | $1.20 | $3.3341 | -12.05% |
| October, 2028 | $2.027 | $1.627 | $3.5398 | -36.36% |
| November, 2028 | $2.2354 | $1.7741 | $2.9712 | -29.81% |
| December, 2028 | $3.7439 | $2.0625 | $4.0768 | +17.55% |
Anbio Biotechnology Stock (NNNN) Price Forecast for 2029
The 2029 price forecast for Anbio Biotechnology Stock (NNNN) is $27.66 on average, with a high prediction of $51.66 and a low estimate of $3.6538. This represents an +768.36% increase from the previous price of $3.185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $27.62 | $3.6538 | $33.02 | +767.17% |
| February, 2029 | $46.65 | $26.53 | $51.66 | +1,365% |
| March, 2029 | $47.01 | $37.09 | $50.39 | +1,376% |
| April, 2029 | $38.77 | $36.82 | $51.06 | +1,117% |
| May, 2029 | $26.10 | $18.31 | $47.56 | +719.48% |
| June, 2029 | $13.42 | $6.819 | $27.44 | +321.32% |
| July, 2029 | $25.30 | $12.74 | $41.12 | +694.49% |
| August, 2029 | $25.95 | $22.48 | $34.44 | +714.85% |
| September, 2029 | $18.45 | $15.04 | $40.98 | +479.33% |
| October, 2029 | $19.52 | $17.04 | $30.56 | +512.78% |
| November, 2029 | $22.39 | $16.74 | $24.19 | +602.84% |
| December, 2029 | $25.28 | $21.71 | $26.70 | +693.76% |
Anbio Biotechnology Stock (NNNN) Price Forecast for 2030
Anbio Biotechnology Stock (NNNN) is expected to reach an average price of $23.81 in 2030, with a high forecast of $47.60 and a low forecast of $0.0262. This signifies an +647.63% surge from the last price of $3.185.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $29.37 | $19.72 | $32.35 | +822.12% |
| February, 2030 | $13.56 | $11.56 | $32.98 | +325.69% |
| March, 2030 | $6.3766 | $5.2866 | $14.94 | +100.21% |
| April, 2030 | $5.8122 | $5.4822 | $10.17 | +82.49% |
| May, 2030 | $3.6807 | $3.4207 | $10.89 | +15.56% |
| June, 2030 | $3.5092 | $2.3049 | $4.142 | +10.18% |
| July, 2030 | $0.1157 | $0.7805 | $3.6563 | -96.37% |
| August, 2030 | $1.0784 | $0.1814 | $1.3184 | -66.14% |
| September, 2030 | $0.1868 | $0.1921 | $1.3997 | -94.14% |
| October, 2030 | $1.2995 | $0.0262 | $1.4395 | -59.20% |
| November, 2030 | $2.5222 | $0.8152 | $2.8978 | -20.81% |
| December, 2030 | $43.25 | $2.4879 | $47.60 | +1,258% |
3.54%
6.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):